OpenAI Launches AI Model for Drug Discovery

OpenAI has launched GPT-Rosalind, an AI model specifically designed to accelerate drug discovery and support biology-related research. The Microsoft-backed AI startup made the announcement on Thursday. The launch is drawing attention to major life sciences companies, with shares of leading firms expected to be in focus following the news.